Stocktoria
Elanco Animal Health Inc ELAN
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-09-20
Elanco Animal Health Inc financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.7B | $4.4B | $4.4B | $4.4B | $4.8B |
| Gross profit | $2.6B | $2.4B | $2.5B | — | — |
| R&D expense | $368.0M | $344.0M | $327.0M | $321.0M | $369.0M |
| SG&A expense | $1.4B | $1.3B | $1.3B | $1.3B | $1.4B |
| Interest expense | — | — | $277.0M | $241.0M | $236.0M |
| Income tax | $8.0M | $150.0M | $36.0M | $6.0M | -$88.0M |
| Net income | -$232.0M | $338.0M | -$1.2B | -$78.0M | -$483.0M |
| EPS (diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 |
| Operating cash flow | $560.0M | $541.0M | $271.0M | $452.0M | $483.0M |
| Free cash flow | $284.0M | $394.0M | $131.0M | $281.0M | $324.0M |
| Cash & equivalents | $545.0M | $468.0M | $352.0M | $345.0M | $638.0M |
| Inventory | $1.7B | $1.6B | $1.7B | $1.5B | $1.4B |
| Total assets | $13.4B | $12.6B | $14.4B | $15.5B | $16.5B |
| Total liabilities | $6.8B | $6.5B | $8.1B | $8.2B | $9.0B |
| Shareholders' equity | $6.5B | $6.1B | $6.2B | $7.3B | $7.5B |
Source: SEC EDGAR filings · CIK 0001739104 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.